msdcapital13d-03112014.htm

0001123292-15-000852.txt : 20150529 0001123292-15-000852.hdr.sgml : 20150529 20150529120508 ACCESSION NUMBER: 0001123292-15-000852 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20150529 DATE AS OF CHANGE: 20150529 GROUP MEMBERS: C.V. STARR & CO., INC. GROUP MEMBERS: MAURICE R. GREENBERG GROUP MEMBERS: STARR GLOBAL FINANCIAL, INC. GROUP MEMBERS: STARR GLOBAL HOLDINGS AG GROUP MEMBERS: STARR INDEMNITY & LIABILITY CO GROUP MEMBERS: STARR INTERNATIONAL COMPANY, INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GRANDPARENTS.COM, INC. CENTRAL INDEX KEY: 0001020475 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 931211114 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78351 FILM NUMBER: 15898112 BUSINESS ADDRESS: STREET 1: 589 EIGHTH AVENUE, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 646-839-8800 MAIL ADDRESS: STREET 1: 589 EIGHTH AVENUE, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: NorWesTech, Inc. DATE OF NAME CHANGE: 20110913 FORMER COMPANY: FORMER CONFORMED NAME: Pacific Biomarkers, Inc. DATE OF NAME CHANGE: 20100212 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOMETRICS INC DATE OF NAME CHANGE: 19960813 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Starr Insurance Holdings, Inc. CENTRAL INDEX KEY: 0001640517 IRS NUMBER: 204924762 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 399 PARK AVENUE STREET 2: 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-227-6300 MAIL ADDRESS: STREET 1: 399 PARK AVENUE STREET 2: 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 SC 13D/A 1 starr13d-05012015.htm msdcapital13d-03112014.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

GRANDPARENTS.COM, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

386617104

(CUSIP Number)

Thomas A. Bryan, Esq.

Starr Insurance Holdings, Inc.

399 Park Ave, 8^th Floor

New York, NY 10022

646-227-6677

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communication)

November 7, 2014

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7 for other parties to whom copies are to be sent.

*	The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP NO.

386617104

SCHEDULE 13D

1	NAMES OF REPORTING PERSONS

		Starr Insurance Holdings, Inc.

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP					(a) o
						(b) x

3	SEC USE ONLY

4	SOURCE OF FUNDS (SEE INSTRUCTIONS)

		AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)					o


6	CITIZENSHIP OR PLACE OF ORGANIZATION

		Nevada

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER

					-0-

			8	SHARED VOTING POWER

					16,079,216

			9	SOLE DISPOSITIVE POWER

					-0-

			10	SHARED DISPOSITIVE POWER

					16,079,216

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

		16,079,216

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)					☒


13	PERCENT OF CLASS REPRESENTED IN ROW (11)*

		10.9%1

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

		HC

* See Item 5, Interest in the Securities of the Issuer, below.

1	Unless otherwise indicated, the ownership percentage reported throughout this Schedule 13D is based on 132,068,582 shares of the Issuer's common stock outstanding as of March 31, 2015, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

CUSIP NO.

386617104

SCHEDULE 13D

1	NAMES OF REPORTING PERSONS

		Starr International Company, Inc.

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP					(a) o
						(b) x

3	SEC USE ONLY

4	SOURCE OF FUNDS (SEE INSTRUCTIONS)

		AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)					o


6	CITIZENSHIP OR PLACE OF ORGANIZATION

		Switzerland

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER

					-0-

			8	SHARED VOTING POWER

					16,079,216

			9	SOLE DISPOSITIVE POWER

					-0-

			10	SHARED DISPOSITIVE POWER

					16,079,216

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

		16,079,216

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)					x


13	PERCENT OF CLASS REPRESENTED IN ROW (11)*

		10.9%1

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

		HC

* See Item 5, Interest in the Securities of the Issuer, below.

CUSIP NO.

386617104

SCHEDULE 13D

1	NAMES OF REPORTING PERSONS

		Starr Global Holdings AG

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP					(a) o
						(b) x

3	SEC USE ONLY

4	SOURCE OF FUNDS (SEE INSTRUCTIONS)

		AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)					o


6	CITIZENSHIP OR PLACE OF ORGANIZATION

		Switzerland

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER

					-0-

			8	SHARED VOTING POWER

					16,079,216

			9	SOLE DISPOSITIVE POWER

					-0-

			10	SHARED DISPOSITIVE POWER

					16,079,216

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

		16,079,216

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)					x


13	PERCENT OF CLASS REPRESENTED IN ROW (11)*

		10.9%1

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

		HC

* See Item 5, Interest in the Securities of the Issuer, below.

CUSIP NO.

386617104

SCHEDULE 13D

1	NAMES OF REPORTING PERSONS

		Starr Global Financial, Inc.

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP					(a) o
						(b) x

3	SEC USE ONLY

4	SOURCE OF FUNDS (SEE INSTRUCTIONS)

		AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)					o


6	CITIZENSHIP OR PLACE OF ORGANIZATION

		Nevada

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER

					-0-

			8	SHARED VOTING POWER

					16,079,216

			9	SOLE DISPOSITIVE POWER

					-0-

			10	SHARED DISPOSITIVE POWER

					16,079,216

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

		16,079,216

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)					x


13	PERCENT OF CLASS REPRESENTED IN ROW (11)*

		10.9%1

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

		HC

* See Item 5, Interest in the Securities of the Issuer, below.

CUSIP NO.

386617104

SCHEDULE 13D

1	NAMES OF REPORTING PERSONS

		Starr Indemnity & Liability Company

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP					(a) o
						(b) x

3	SEC USE ONLY

4	SOURCE OF FUNDS (SEE INSTRUCTIONS)

		WC

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)					o


6	CITIZENSHIP OR PLACE OF ORGANIZATION

		Texas

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER

					-0-

			8	SHARED VOTING POWER

					16,079,216

			9	SOLE DISPOSITIVE POWER

					-0-

			10	SHARED DISPOSITIVE POWER

					16,079,216

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

		16,079,216

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)					x


13	PERCENT OF CLASS REPRESENTED IN ROW (11)*

		10.9%1

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

		IC

* See Item 5, Interest in the Securities of the Issuer, below.

CUSIP NO.

386617104

SCHEDULE 13D

1	NAMES OF REPORTING PERSONS

		C.V. Starr & Co., Inc.

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP					(a) o
						(b) x

3	SEC USE ONLY

4	SOURCE OF FUNDS (SEE INSTRUCTIONS)

		WC

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)					o


6	CITIZENSHIP OR PLACE OF ORGANIZATION

		Nevada

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER

					-0-

			8	SHARED VOTING POWER

					5,000,000

			9	SOLE DISPOSITIVE POWER

					-0-

			10	SHARED DISPOSITIVE POWER

					5,000,000

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

		5,000,000

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)					x


13	PERCENT OF CLASS REPRESENTED IN ROW (11)*

		3.8%1

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

		CO

* See Item 5, Interest in the Securities of the Issuer, below.

CUSIP NO.

386617104

SCHEDULE 13D

1	NAMES OF REPORTING PERSONS

		Maurice R. Greenberg

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP					(a) o
						(b) x

3	SEC USE ONLY

4	SOURCE OF FUNDS (SEE INSTRUCTIONS)

		AF

5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)					o


6	CITIZENSHIP OR PLACE OF ORGANIZATION

		United States

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH			7	SOLE VOTING POWER

					-0-

			8	SHARED VOTING POWER

					5,000,000

			9	SOLE DISPOSITIVE POWER

					-0-

			10	SHARED DISPOSITIVE POWER

					5,000,000

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

		5,000,000

12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)					x


13	PERCENT OF CLASS REPRESENTED IN ROW (11)*

		3.8%1

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

		IN

* See Item 5, Interest in the Securities of the Issuer, below.

EXPLANATORY NOTE

This statement on Schedule 13D (the "Statement") was originally filed to report the Reporting Persons' (as defined hereinafter) holdings of shares of common stock of Grandparents.com as of (1) November 7, 2014, the first date on which any Reporting Person could be deemed to have beneficially owned more than 5% of the outstanding shares of the common stock, and (2) except to the extent previously reported in this Statement, on each date thereafter on which the number of shares of the outstanding shares beneficially owned by any Reporting Person increased or decreased by an amount equal to or exceeding one percent of the class outstanding (each, a "Subsequent Amendment Date"). Information regarding the holdings of each Reporting Person as of March 1, 2015 (the most recent Subsequent Amendment Date is set forth on the cover page hereto, and information regarding each Reporting Person's holdings as of November 7, 2014 and as of the Subsequent Amendment Date is set forth in Item 5 hereof.

By filing this Amendment No. 1, the Reporting Persons are amending and restating in the entirety the disclosures contained in the Schedule 13D originally filed on May 7, 2015 due to the fact that the initial filing erroneously failed to include the effect of an immediately exercisable warrant to purchase 1,000,000 shares of the Issuer's common stock that was issued in connection with the issuance of common stock reported in Item 3.

Item 1.

Security and Issuer

This statement relates to the common stock, $0.01 par value per share (the "Shares"), of Grandparents.com, Inc., a Delaware corporation (the "Issuer"). The address of the principal executive offices of the Issuer is 589 Eighth Avenue, New York, NY 10018.

Item 2.

Identity and Background

(a) The names of the persons filing this Schedule 13D are Starr Insurance Holdings, Inc., a Nevada corporation ("SIH"), Starr International Company, Inc., a company formed under the laws of Switzerland ("SIC"), Starr Global Holdings AG, a company formed under the laws of Switzerland ("SGH"), Star Global Financial, Inc., a Nevada corporation ("SGF"), Starr Indemnity & Liability Company, a Texas corporation ("SILC"), C.V. Starr & Co., Inc., a Nevada corporation ("CVS") and Maurice R. Greenberg. SIH, SIC, SGH, SGF, SILC, CVS and Mr. Greenberg are collectively referred to in this Schedule 13D as the "Reporting Persons." The Reporting Persons are filing this Statement jointly, as they may be considered a "group" under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended. However, neither the fact of this filing nor anything contained herein shall be deemed to be an admission by the Reporting Persons that such a group exists.

The executive officers and directors of each of SIH, SIC, SGH, SGF, SILC, and CVS, their addresses, their present principal occupations and citizenship, if other than the United States, are disclosed as Schedule A to this Statement.

(b) The principal business address of each of the Reporting Persons is 399 Park Ave, 8^th Floor, New York, New York 10022.

(c) This Schedule 13D is filed on behalf of the Reporting Persons. SIH is the record and beneficial owner of warrants to purchase 21,438,954 Shares (the "Warrant Shares"), which warrants were issued on November 7, 2014 and carry an exercise price of $0.05 per Share, subject to adjustment. On the date of issuance, the warrants were immediately exercisable for 50% (10,719,477 Shares) of the aggregate amount thereof. An additional 25% (5,359,739 Shares) of the total Warrant Shares became exercisable on March 1, 2015. SIH is a wholly owned subsidiary of SGH, which is a wholly owned subsidiary of SIC. SILC may be deemed to be the beneficial owners of the Warrant Shares owned beneficially and of record by SIH, because the warrants were issued pursuant to a Strategic Alliance Agreement between SILC and the Issuer. SILC is a wholly owned subsidiary of SGF, which is a wholly owned subsidiary of SIH. As a result, SIC may be deemed to beneficially own securities owned beneficially or of record by SIH or SILC. CVS is the record and beneficial owner of 4,000,000 Shares, which were issued on June 19, 2014. Mr. Greenberg is the control member of, and may be deemed to beneficially own securities beneficially owned by CVS.

CVS is the record and beneficial owner of 4,000,000 Shares, and has the right to acquire an additional 1,000,000 Shares pursuant to a presently exercisable warrant allotment which were issued on June 16, 2014. Mr. Greenberg is the control member of, and may be deemed to beneficially own securities beneficially owned by CVS.

The principal business of each of SIH, SIC, SGH, and SGF is to be a holding company of regulated insurance companies. The principal business of SILC is to be a property and casualty insurance company. The principal business of CVS is to make global investments. Mr. Greenberg is the chief executive officer of CVS and SIH.

The Reporting Persons have entered into a Joint Filing Agreement, dated May 4, 2015, a copy of which was filed with the initial Schedule 13D as Exhibit 99.2, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.

Neither the filing of this statement nor anything herein shall be construed as an admission that CVS and Mr. Greenberg beneficially own securities beneficially owned by SIC, SGH, SIH, SGF or SILC. CVS and Mr. Greenberg disclaim beneficial ownership of the Shares held by SIC, SGH, SIH, SGF and SILC. Neither the filing of this statement nor anything herein shall be construed as an admission that SIC, SGH, SIH, SGF or SILC beneficially own securities beneficially owned by CVS and Mr. Greenberg. SIC, SGH, SIH, SGF and SILC disclaim beneficial ownership of the Shares held by CVS and Mr. Greenberg except to the extent of their pecuniary interest therein.

(d) During the last five years, none of the foregoing entities or persons has been convicted in a criminal proceeding of the type specified in Item 2(d) of Schedule 13D.

(e) During the last five years, none of the foregoing entities or persons has been a party to a civil proceeding of the type specified in Item 2(e) of Schedule 13D.

(f) SIC is organized under the laws of Switzerland. SGH is organized under the laws of Switzerland. SIH is organized under the laws of the State of Nevada. SGF is organized under the laws of the State of Nevada. SILC is organized under the laws of the State of Texas. CVS is organized under the laws of the State of Nevada. Mr. Greenberg is a citizen of the United States.

Item 3.

Source and Amount of Funds or Other Consideration

Warrants to purchase 21,438,954 Shares were issued by the Issuer to SIH on November 7, 2014. The warrants were issued pursuant to a Strategic Alliance Agreement between the Issuer and SILC dated January 8, 2013 and filed with this Schedule 13D as Exhibit 99.3, as amended by a First Amendment to Strategic Alliance Agreement dated April 11, 2013 and filed with this Schedule 13D as Exhibit 99.4. The primary purpose of the Strategic Alliance Agreement was for the Issuer to develop strategic business and investment relationships in connection with the development of the Issuer's business. The warrants are filed as Exhibit 99.5 and 99.6 of this Schedule 13D. The warrants were immediately exercisable for 10,719,477 Shares on November 7, 2014. Warrants for an additional 5,359,737 Shares first became exercisable on March 1, 2015, and the warrants will be fully exercisable for all shares on March 1, 2016.

SILC funded its obligations under the Strategic Alliance Agreement using working capital. The exercise price of any warrants would also be funded with working capital, if and when exercised.

CVS acquired 4,000,000 Shares and a presently exercisable warrant to purchase 1,000,000, Shares from the Issuer on June 16, 2014 for an aggregate purchase price of $1,000,000 using general corporate funds. The securities were issued pursuant to a Securities Purchase Agreement dated June 16, 2014 which is filed herewith as Exhibit 99.6. The warrant issued to CVS is filed herewith as Exhibit 99.7.

Item 4.

Purpose of the Transaction

The Securities covered by this statement were originally acquired in the ordinary course of business solely for investment purposes and for the business purposes contemplated by the Strategic Alliance Agreement as described in Item 3 and not for the purposes of participating in or influencing the management of the Issuer.

None of the Reporting Persons currently has any plans or proposals that relate to or would result in any of the actions specified in clause (a) through (j) of Item 4 of Schedule 13D. To the extent deemed advisable in light of their general investment policies, or other factors, the Reporting Persons may, at any time and from time to time, formulate other purposes, plans or proposals regarding the Issuer or the Shares, or any other actions that could involve one or more of the types of transactions or have one or more of the results described in paragraphs (a) through (j) of Item 4 of Schedule 13D. The foregoing is subject to change at any time, and there can be no assurance that either of the Reporting Persons will take any of the actions set forth above.

Each of the Reporting Persons reserves the right, in light of its ongoing evaluation of the Issuer's financial condition, business, operations and prospects, the market price of the Shares, conditions in the securities markets generally, general economic and industry conditions, its business objectives and other relevant factors, to change its plans and intentions at any time, as it deems appropriate. In particular, any one or more of the Reporting Persons (and their respective affiliates) reserves the right, in each case subject to any applicable law to (i) purchase Shares or other securities of the Issuer, including through exercise of the Warrants,, (ii) sell or transfer the securities beneficially owned by them from time to time in public or private transactions, and (iii) enter into privately negotiated derivative transactions with institutional counterparties to hedge the market risk of some or all of their positions in the securities of the Issuer.

Item 5.

Interest in Securities of the Issuer

Items 5(a) and (b): The tables below set forth (i) the number of Shares beneficially owned by each Reporting Persons as of November 7, 2014 and as of each Subsequent Amendment Date and (ii) the percentage of the Shares beneficially owned by each of the Reporting Persons as of each such date, calculated based upon the total number of shares outstanding reported in the most recent Quarterly Report on Form 10-Q filed by the Issuer. Each of the Reporting Persons has a shared power to vote and shared power to dispose the Shares disclosed in the tables below.

A.	Starr International Company, Inc.

	Starr International Company, Inc.
Date	Number of Shares (1)	Percent Ownership
November 7, 2014	10,719,477	7.8 (2)
March 1, 2015	16,079,216	10.9 (3)

(1)	Number of Shares over which SIC has shared power to vote and shared power to dispose.

(2)	The percentage is based on 126,999,492shares of the Issuer's common stock outstanding as of September 30, 2014 as reported in the Issuer's Form 10-Q filed with the Commission on November 13, 2014).

(3)	The percentage is based on 132,068,582 shares of the Issuer's common stock outstanding as of March 31, 2015, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

B.	Starr Global Holdings AG

	Starr Global Holdings AG
Date	Number of Shares (1)	Percent Ownership
November 7, 2014	10,719,477	7.8 (2)
March 1, 2015	16,079,216	10.9 (3)

(1)	Number of Shares over which SGH has shared power to vote and shared power to dispose.

(2)	The percentage is based on 126,999,492shares of the Issuer's common stock outstanding as of September 30, 2014 as reported in the Issuer's Form 10-Q filed with the Commission on November 13, 2014).

(3)	The percentage is based on 132,068,582 shares of the Issuer's common stock outstanding as of March 31, 2015, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

C.	Starr Insurance Holdings, Inc.

	Starr Insurance Holdings, Inc.
Date	Number of Shares (1)	Percent Ownership
November 7, 2014	10,719,477	7.8 (2)
March 1, 2015	16,079,216	10.9 (3)

(1)	Number of Shares over which SIH has shared power to vote and shared power to dispose.

(2)	The percentage is based on 126,999,492shares of the Issuer's common stock outstanding as of September 30, 2014 as reported in the Issuer's Form 10-Q filed with the Commission on November 13, 2014).

(3)	The percentage is based on 132,068,582 shares of the Issuer's common stock outstanding as of March 31, 2015, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

D.	Starr Global Financial, Inc.

	Starr Global Financial, Inc.
Date	Number of Shares (1)	Percent Ownership
November 7, 2014	10,719,477	7.8 (2)
March 1, 2015	16,079,216	10.9 (3)

(1)	Number of Shares over which SGF has shared power to vote and shared power to dispose.

(2)	The percentage is based on 126,999,492shares of the Issuer's common stock outstanding as of September 30, 2014 as reported in the Issuer's Form 10-Q filed with the Commission on November 13, 2014).

(3)	The percentage is based on 132,068,582 shares of the Issuer's common stock outstanding as of March 31, 2015, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

E.	Starr Indemnity & Liability Company

	Starr Indemnity & Liability Company
Date	Number of Shares (1)	Percent Ownership
November 7, 2014	10,719,477	7.8 (2)
March 1, 2015	16,079,216	10.9 (3)

(1)	Number of Shares over which SILC has shared power to vote and shared power to dispose.

(2)	The percentage is based on 126,999,492shares of the Issuer's common stock outstanding as of September 30, 2014 as reported in the Issuer's Form 10-Q filed with the Commission on November 13, 2014).

(3)	The percentage is based on 132,068,582 shares of the Issuer's common stock outstanding as of March 31, 2015, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

F.	C.V. Starr & Company, Inc.

	C.V. Starr & Company, Inc.
Date	Number of Shares (1)	Percent Ownership
November 7, 2014	5,000,000	3.9 (2)
March 1, 2015	5,000,000	3.8 (3)

(1)	Number of Shares over which CVS has shared power to vote and shared power to dispose.

(2)	The percentage is based on 126,999,492shares of the Issuer's common stock outstanding as of September 30, 2014 as reported in the Issuer's Form 10-Q filed with the Commission on November 13, 2014).

(3)	The percentage is based on 132,068,582 shares of the Issuer's common stock outstanding as of March 31, 2015, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

G.	Maurice R. Greenberg

	Maurice R. Greenberg
Date	Number of Shares (1)	Percent Ownership
November 7, 2014	5,000,000	3.9 (2)
March 1, 2015	5,000,000	3.8 (3)

(1)	Number of Shares over which Mr. Greenberg has shared power to vote and shared power to dispose.

(2)	The percentage is based on 126,999,492shares of the Issuer's common stock outstanding as of September 30, 2014 as reported in the Issuer's Form 10-Q filed with the Commission on November 13, 2014).

(3)	The percentage is based on 132,068,582 shares of the Issuer's common stock outstanding as of March 31, 2015, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

As of March 1, 2015 (the most recent Subsequent Amendment Date), the Reporting Persons, in aggregate, beneficially own 21,079,216 Shares, which represent 14.2% of the total shares of the Issuer outstanding, based on the Issuer's common stock as of March 31, 2015 as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

Item 5(c):

On March 1, 2015, 25% (5,359,739 Shares) of the total Warrant Shares beneficially owned by SIH first became exercisable at a price of $0.05 per share. As of the filing of this Statement, 75% (16,079,216 Shares) of the total Warrant Shares are exercisable. The Warrant Shares will be exercisable in full on March 1, 2016.

Item 5(d):

Not applicable.

Item 5(e):

Not Applicable.

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Except as otherwise described herein, none of the Reporting Persons has any legal or other contract, arrangement, understanding, or relationship with any other person with respect to any securities of the Issuer.

Item 7.		Material to be filed as Exhibits

Exhibit		Description of Exhibit


99.1		Joint Filing Agreement dated May 1, 2015 (incorporated by reference to the Reporting Persons initial Schedule 13D filed on May 7, 2015.)
99.2		Strategic Alliance Agreement with Starr Indemnity & Liability Company dated January 8, 2013 (incorporated herein by reference to Exhibit 10.1 to the Issuer's Current Report on Form 8-K dated January 8, 2013).
99.3		First Amendment to Strategic Alliance Agreement with Starr Indemnity & Liability Company dated March 28, 2013 (Incorporated herein by reference to Exhibit 10.35 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2012).
99.4		Warrant No. GP-185 to Purchase Common Stock of the Issuer issued pursuant to the Strategic Alliance Agreement (incorporated by reference to the Reporting Persons initial Schedule 13D filed on May 7, 2015).
99.5		Warrant No. GP-186 to Purchase Common Stock of the Issuer issued pursuant to the Strategic Alliance Agreement (incorporated by reference to the Reporting Persons initial Schedule 13D filed on May 7, 2015).
99.6		Securities Purchase Agreement dated as of June 16, 2014 between Grandparents.com, Inc. and C.V. Starr & Company, Inc. (filed herewith).
99.7		Warrant No. GP-155 to purchase common stock of the Issuer to the Securities Purchase Agreement (filed herewith).

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: May 29, 2015.

	STARR INTERNATIONAL COMPANY, INC.

	By:	/s/ Stuart Osborne
		Stuart Osborne, Vice President

	STARR GLOBAL HOLDINGS AG

	By:	/s/ Bertil Lundvist
		Bertil Lundqvist, Director

	STARR INSURANCE HOLDINGS, INC.

	By:	/s/ Julie A. Murray
		Julie A. Murray, Assistant Secretary

	STARR GLOBAL FINANCIAL, INC.

	By:	/s/ Thomas A. Bryan
		Thomas A. Bryan, Assistant Secretary

	STARR INDEMNITY & LIABILITY COMPANY

	By:	/s/ Julie A. Murray
		Julie A. Murray, Assistant Secretary

	C.V. STARR & COMPANY, INC.

	By:	/s/ Thomas A. Bryan
		Thomas A. Bryan, Assistant Secretary

	/s/ Maurice R. Greenberg
	Maurice R. Greenberg

SCHEDULE A

STARR INTERNATIONAL COMPANY, INC.
Name and Address (Citizenship, if Non U.S.)	Office	Principal Occupation
Lawrence Scott Greenberg 399 Park Avenue, 17^th Floor New York, NY 10022	Director	Insurance Executive, C.V. Starr & Co., Inc.
Maurice R. Greenberg 399 Park Avenue, 17^th Floor New York, NY 10022	Director and Managing Director	Chairman and CEO, C.V. Starr & Co., Inc.
Joseph C.H. Johnson (Bermuda) Bermuda Commercial Bank Bldg. 19 Par la Ville Road, 5^th Floor Hamilton Bermuda HM11	Director and President	Director, Starr International Investment, Ltd.
Lord Peter Levene (UK) 399 Park Avenue, 17^th Floor New York, NY 10022	Director	Vice Chairman, Starr International Co., Inc.
Bertil P. Lundqvist 399 Park Avenue, 17^th Floor New York, NY 10022	Director and Vice President	Executive Vice President and General Counsel, Starr Insurance Holdings, Inc. and C.V. Starr & Co., Inc.
Edward E. Matthews 399 Park Avenue, 17^th Floor New York, NY 10022	Director and Vice President	President, C.V. Starr & Co., Inc.
Howard I. Smith 399 Park Avenue, 17^th Floor New York, NY 10022	Director and Vice President	Vice Chairman, C.V. Starr & Co., Inc.
Stuart Osborne (United Kingdom) Baarerstrasse 101, CH 6300, Zug Switzerland	Vice President, Secretary and Treasurer	Accounting Officer, Starr International Service AG
Margaret Barnes (United Kingdom and Canada) Baarerstrasse 101, CH 6300, Zug Switzerland	Vice President and Controller	Insurance Professional, Starr International Investment, Ltd.

STARR GLOBAL HOLDINGS AG
Name and Address (Citizenship, if Non U.S.)	Office	Principal Occupation
Bertil P. Lundqvist 399 Park Avenue, 17^th Floor New York, NY 10022	Director	Executive Vice President and General Counsel, Starr Insurance Holdings, Inc. and C.V. Starr & Co., Inc.
Edward E. Matthews 399 Park Avenue, 17^th Floor New York, NY 10022	Director	President, C.V. Starr & Co., Inc.
Stuart Osborne (United Kingdom) Baarerstrasse 101, CH 6300, Zug Switzerland	Director	Accounting Officer, Starr International Service AG

STARR INSURANCE HOLDINGS, INC.
Name and Address	Office	Principal Occupation
Maurice R. Greenberg 399 Park Avenue, 17^th Floor New York, NY 10022	Chairman and Chief Executive Officer	Chairman and CEO, C.V. Starr & Co., Inc.
Bertil P. Lundqvist 399 Park Avenue, 17^th Floor New York, NY 10022	Director, Executive Vice President and General Counsel	Executive Vice President and General Counsel, Starr Insurance Holdings, Inc. and C.V. Starr & Co., Inc.
Edward E. Matthews 399 Park Avenue, 17^th Floor New York, NY 10022	Vice Chairman	President, C.V. Starr & Co., Inc.
Charles Dangelo 399 Park Avenue, 17^th Floor New York, NY 10022	President and Chief Operating Officer	President and Chief Operating Officer, Starr Insurance Holdings, Inc.
Leilani Brown 399 Park Avenue, 17^th Floor New York, NY 10022	Vice President	Vice President, Starr Insurance Holdings, Inc.
Jayson Hahn 399 Park Avenue, 17^th Floor New York, NY 10022	Chief Technology Officer	Chief Technology Officer, Starr Insurance Holdings, Inc.
Michael T. Toran 399 Park Avenue, 17^th Floor New York, NY 10022	Vice President and Chief Information Officer	Vice President and Chief Information Officer, Starr Insurance Holdings, Inc.
Nehemiah Ginsburg 399 Park Avenue, 17^th Floor New York, NY 10022	Senior Vice President and Senior Counsel and Secretary	Senior Vice President and Senior Counsel and Secretary Starr Insurance Holdings, Inc.
William Tucker 399 Park Avenue, 17^th Floor New York, NY 10022	Treasurer	Treasurer, Starr Insurance Holdings, Inc.
John Cunningham 399 Park Avenue, 17^th Floor New York, NY 10022	Vice President	Vice President, Starr Insurance Holdings, Inc.
Michael J. Castelli 399 Park Avenue, 17^th Floor New York, NY 10022	Chief Financial Officer and Senior Vice President	Chief Financial Officer and Senior Vice President, Starr Insurance Holdings, Inc.
John Cunningham 399 Park Avenue, 17^th Floor New York, NY 10022	Chief Financial Systems Officer	Chief Financial Systems Officer, Starr Insurance Holdings, Inc.
Clifford Karlin 399 Park Avenue, 17^th Floor New York, NY 10022	Vice President, Operations	Vice President, Operations, Starr Insurance Holdings, Inc.

STARR GLOBAL FINANCIAL, INC.
Name and Address	Office	Principal Occupation
Bertil P. Lundqvist 399 Park Avenue, 17^th Floor New York, NY 10022	Vice Chairman and Director	Executive Vice President and General Counsel, Starr Insurance Holdings, Inc. and C.V. Starr & Co., Inc.
Edward E. Matthews 399 Park Avenue, 17^th Floor New York, NY 10022	Chairman and Director	President, C.V. Starr & Co., Inc.
Charles Dangelo 399 Park Avenue, 17^th Floor New York, NY 10022	President	President and Chief Operating Officer, Starr Insurance Holdings, Inc.
William Tucker 399 Park Avenue, 17^th Floor New York, NY 10022	Treasurer	Treasurer, Starr Insurance Holdings, Inc.
Nehemiah Ginsburg 399 Park Avenue, 17^th Floor New York, NY 10022	Secretary	Senior Vice President and Senior Counsel and Secretary Starr Insurance Holdings, Inc.

STARR INDEMNITY & LIABILITY COMPANY
Name and Address (Citizenship, if Non U.S.)	Office	Principal Occupation
Michael J. Castelli 399 Park Avenue, 17^th Floor New York, NY 10022	Director	Chief Financial Officer and Senior Vice President , Starr Insurance Holdings, Inc.
Charles Dangelo 399 Park Avenue, 17^th Floor New York, NY 10022	Director, President and Chief Executive Officer	President and Chief Operating Officer, Starr Insurance Holdings, Inc.
Nehemiah Ginsburg 399 Park Avenue, 17^th Floor New York, NY 10022	Director	Senior Vice President and Senior Counsel and Secretary Starr Insurance Holdings, Inc.
Jacob E. Hansen 399 Park Avenue, 17^th Floor New York, NY 10022	Director	Director, Starr Indemnity & Liability Company
Joseph C.H. Johnson (Bermuda) Bermuda Commercial Bank Bldg. 19 Par la Ville Road, 5^th Floor Hamilton Bermuda HM11	Director	Director, Starr International Investment, Ltd.
Charles Reid 399 Park Avenue, 17^th Floor New York, NY 10022	Director	Director, Starr Indemnity & Liability Company
John Salinger 399 Park Avenue, 17^th Floor New York, NY 10022	Director	Director, Starr Indemnity & Liability Company
William Tucker 399 Park Avenue, 17^th Floor New York, NY 10022	Chief Financial Officer and Treasurer	Treasurer, Starr Insurance Holdings, Inc.
Michael Toran 399 Park Avenue, 17^th Floor New York, NY 10022	Vice President and Chief Information Officer	Vice President and Chief Information Officer, Starr Insurance Holdings, Inc.
Richard A. Bessinger 399 Park Avenue, 17^th Floor New York, NY 10022	Senior Vice President	Senior Vice President, Starr Indemnity & Liability Company
David H. Baker 399 Park Avenue, 17^th Floor New York, NY 10022	Vice President	Vice President, Starr Indemnity & Liability Company
Alex J. Pittignano 399 Park Avenue, 17^th Floor New York, NY 10022	Vice President	Vice President, Starr Indemnity & Liability Company
James Pittinger 399 Park Avenue, 17^th Floor New York, NY 10022	Vice President	Vice President, Starr Indemnity & Liability Company
Richard Thomas 399 Park Avenue, 17^th Floor New York, NY 10022	Vice President	Vice President, Starr Indemnity & Liability Company
Jeffrey Johnson 399 Park Avenue, 17^th Floor New York, NY 10022	Chief Property/Casualty Claims Officer	Chief Property/Casualty Claims Officer, Starr Indemnity & Liability Company
James Vendetti 399 Park Avenue, 17^th Floor New York, NY 10022	Executive Vice President and Chief Underwriting Officer	Executive Vice President and Chief Underwriting Officer, Starr Indemnity & Liability Company

C.V. STARR & COMPANY, INC.
Name and Address	Office	Principal Occupation
Geoffrey Clark 399 Park Avenue, 17^th Floor New York, NY 10022	Director	Managing Director, Starr Investments Holdings LLC
Lawrence Scott Greenberg 399 Park Avenue, 17^th Floor New York, NY 10022	Director	Insurance Executive, C.V. Starr & Co., Inc.
Maurice R. Greenberg 399 Park Avenue, 17^th Floor New York, NY 10022	Chairman and Chief Executive Officer	Chairman and CEO, C.V. Starr & Co., Inc.
Bertil P. Lundqvist 399 Park Avenue, 17^th Floor New York, NY 10022	Director, Executive Vice President and General Counsel	Executive Vice President and General Counsel, Starr Insurance Holdings, Inc. and C.V. Starr & Co., Inc.
Edward E. Matthews 399 Park Avenue, 17^th Floor New York, NY 10022	Vice Chairman	President, C.V. Starr & Co., Inc.
Howard I. Smith 399 Park Avenue, 17^th Floor New York, NY 10022	Vice Chairman	Vice Chairman, C.V. Starr & Co., Inc.
John Casale 399 Park Avenue, 17^th Floor New York, NY 10022	Treasurer	Treasurer, C.V. Starr & Co., Inc.
Michael J. Castelli 399 Park Avenue, 17^th Floor New York, NY 10022	Controller	Controller, C.V. Starr & Co., Inc.
Oakley Johnson 399 Park Avenue, 17^th Floor New York, NY 10022	Vice President	Vice President, C.V. Starr & Co., Inc.
Thomas A. Bryan 399 Park Avenue, 17^th Floor New York, NY 10022	Assistant Secretary	Assistant Secretary, C.V. Starr & Co., Inc.

EX-99.6 2 exhibit-99-6.htm

Exhibit 99.6

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this "Agreement") is dated as of June 16, 2014 by and between Grandparents.com, Inc., a Delaware corporation (the "Company"), and CV Starr & Company, Inc. (the "Purchaser").

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(2) of the Securities Act of 1933, as amended, the Company desires to issue and sell to the Purchaser, and the Purchaser desires to purchase from the Company, certain securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and the Purchaser agree as follows:

ARTICLE I
DEFINITIONS

1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated:

"Affiliate" means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 144 under the Securities Act.

"Business Day" means any day other than Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by law to remain closed.

"Closing" means the closing of the purchase and sale of the Shares and the Warrant pursuant to Section 2.1 hereof.

"Closing Date" means the date of the Closing.

"Commission" means the Securities and Exchange Commission.

"Common Stock" means the common stock of the Company, par value $0.01 per share.

"Exchange Act" means the Securities Exchange Act of 1934, as amended.

"Lien" means any lien, charge, claim, security interest, encumbrance, right of first refusal or other restriction.

"Person" means any individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or any court or other federal, state, local or other governmental authority or other entity of any kind.

"Registrable Securities" means (i) any of the Shares; (ii) any of the Underlying Shares issued or issuable upon the exercise of the Warrant and (ii) any shares of Common Stock issued or to be issued with respect to the Shares or the Underlying Shares issued or issuable upon the exercise of the Warrant by way of a stock dividend or stock split. As to any particular Registrable Security, such security will cease to be a Registrable Security when it (x) has been effectively registered under the Securities Act and disposed of in accordance with the registration statement covering such security, (y) has been transferred through a broker-dealer in an open market transaction pursuant to Rule 144 (or any similar provision then in force) or (z) is eligible for sale pursuant to Rule 144(b) (or any similar provision then in force).

"Rule 144" means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

"Securities" means the Shares, the Warrant and the Underlying Shares. "Securities Act" means the Securities Act of 1933, as amended.

"Shares" means an aggregate of 4,000,000 shares of Common Stock, which are being issued and sold to the Purchaser at the Closing.

"Transaction Documents" means this Agreement, the Warrant, and any other documents or agreements executed in connection with the transactions contemplated hereunder.

"Underlying Shares" means the shares of Common Stock issuable upon exercise of the Warrant and any securities issued in exchange for or in respect of such shares.

"Warrant" means, the Common Stock purchase warrant issued and sold under this Agreement, in the form of Exhibit A, and any warrant issued upon exercise of such warrant.

ARTICLE II
PURCHASE AND SALE

2.1 Closing. Subject to the terms and conditions set forth in this Agreement, at the Closing the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, 4,000,000 Shares and a Warrant to purchase 1,000,000 Underlying Shares, for an aggregate purchase price equal to $1,000,000. The Closing shall take place at the offices of Sills Cummis & Gross, PC immediately following the execution hereof, or at such other location or time as the parties may agree.

2.2 Deliveries. At the Closing, the Purchaser shall deliver or cause to be delivered to the Company the purchase price indicated in Section 2.1 above, in United States dollars and in immediately available funds, by wire transfer to an account designated in writing by the Company for such purpose. Promptly following the Closing, the Company shall deliver or cause to be delivered to the Purchaser the following: (i) one or more stock certificates, free and clear of all restrictive and other legends (except as expressly provided in Section 4.1(b) hereof), evidencing the number of Shares in Section 2.1 above, registered in the name of the Purchaser; and (ii) a Warrant, registered in the name of the Purchaser, pursuant to which the Purchaser shall have the right to acquire the number of Underlying Shares indicated in Section 2.1 above, on the terms set forth therein.

ARTICLE III
REPRESENTATIONS AND WARRANTIES

3.1 Representations and Warranties of the Company. The Company hereby represents and warrants to the Purchaser as follows:

(a) Organization and Qualification. The Company is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. The Company is not in violation of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. The Company is duly qualified to do business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not, individually or in the aggregate, (i) adversely affect the legality, validity or enforceability of any Transaction Document, (ii) have or result in a material adverse effect on the results of operations, assets, prospects, business or condition (financial or otherwise) of the Company, taken as a whole, or (iii) adversely impair the Company's ability to perform fully on a timely basis its obligations under any of the Transaction Documents (any of (i), (ii) or (iii), a "Material Adverse Effect").

(b) Authorization: Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by each of the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further consent or action is required by the Company, its Board of Directors or its stockholders. Each of the Transaction Documents has been (or upon delivery will be) duly executed by the Company and is, or when delivered in accordance with the terms hereof, will constitute, the valid and binding obligation of the Company enforceable against the Company in accordance with its terms.

(c) No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company's certificate or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company debt or otherwise) or other understanding to which the Company is a party or by which any property or asset of the Company is bound or affected, except to the extent that such conflict, default or termination right could not reasonably be expected to have a Material Adverse Effect, or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company is subject (including federal and state securities laws and regulations and the rules and regulations of any self-regulatory organization to which the Company or its securities are subject), or by which any property or asset of the Company is bound or affected.

(d) Issuance of the Securities. The Securities (including the Underlying Shares) are duly authorized and, when issued and paid for in accordance with the Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens and shall not be subject to preemptive rights or similar rights of stockholders. The Company has reserved from its duly authorized capital stock the number of Underlying Shares.

(e) SEC Reports; Financial Statements. The Company has filed all reports required to be filed by it under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law to file such material) (the foregoing materials being collectively referred to herein as the "SEC Reports" and, together with this Agreement, the "Disclosure Materials") on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved ("GAAP"), except as may be otherwise specified in such financial statements or the notes thereto, and fairly present in all material respects the financial position of the Company and its consolidated subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

(f) Absence of Litigation. There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self- regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company that could, individually or in the aggregate, have a Material Adverse Effect.

(g) Certain Fees. The Company has not taken any action that would cause the Purchaser to be liable for any brokerage or finder's fees or commissions payable to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person engaged by the Company, if any, with respect to the transactions contemplated by this Agreement.

(h) Private Placement. Neither the Company nor any Person acting on the Company's behalf has sold or offered to sell or solicited any offer to buy the Securities by means of any form of general solicitation or advertising. Neither the Company nor any of its Affiliates or any Person acting on the Company's behalf has, directly or indirectly, at any time within the past six months, made any offer or sale of any security or solicitation of any offer to buy any security under circumstances that would (i) eliminate the availability of the exemption from registration under Regulation D under the Securities Act in connection with the offer and sale of the Securities as contemplated hereby or (ii) cause the offering of the Securities pursuant to the Transaction Documents to be integrated with prior offerings by the Company for purposes of any applicable law, regulation or stockholder approval provisions. The Company is not, and is not an Affiliate of, an "investment company" within the meaning of the Investment Company Act of 1940, as amended. The Company is not a United States real property holding corporation within the meaning of the Foreign Investment in Real Property Tax Act of 1980.

3.2 Representations and Warranties of Purchaser. The Purchaser hereby represents and warrants to the Company as follows:

(a) Authority. If the Purchaser is an individual, the Purchaser represents and warrants to the Company that (i) the Purchaser is at least 18 years of age and is legally competent to execute this Agreement, (ii) this Agreement and the other Transaction Documents to which it is a party constitute valid and binding obligations of the Purchaser enforceable against the Purchaser in accordance with the terms hereof and thereof, and (iii) the address shown under the Purchaser's signature at the end of this Agreement is the Purchaser's principal residence. If the Purchaser is an entity, the Purchaser represents and warrants to the Company that (i) the Purchaser is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with the requisite corporate, partnership, limited liability company or other organization power and authority to enter into and to consummate the transactions contemplated by this Agreement and the other Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder, (ii) the purchase by the Purchaser of the Shares and the Warrant hereunder has been duly authorized by all necessary action on the part of the Purchaser, (iii) this Agreement and the other Transaction Documents to which it is a party have been duly executed and delivered by the Purchaser and constitute valid and binding obligations of the Purchaser enforceable against the Purchaser in accordance with the terms hereof and thereof, and (iv) and the Purchaser has its principal offices or principal place of business located at the address shown under Subscriber's signature at the end of this Agreement.

(b) Investment Intent. The Purchaser is acquiring the Securities as principal for its own account for investment purposes only and not with a view to or for distributing or reselling such Securities or any part thereof, without prejudice, however, to the Purchaser's right, subject to the provisions of this Agreement, at all times to sell or otherwise dispose of all or any part of such Securities pursuant to an effective registration statement under the Securities Act or under an exemption from such registration and in compliance with applicable federal and state securities laws. Nothing contained herein shall be deemed a representation or warranty by the Purchaser to hold Securities for any period of time. The Purchaser does not have any agreement or understanding, directly or indirectly, with any Person to distribute any of the Securities.

(c) Purchaser Status. At the time the Purchaser was offered the Shares and the Warrant, it was, and at the date hereof it is, an "accredited investor" as defined in Rule 501(a) of Regulation D under the Securities Act. The Purchaser is not a registered broker-dealer under Section 15 of the Exchange Act.

(d) Experience of Purchaser. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

(e) Access to Information. The Purchaser acknowledges that it has received and reviewed all information about the Company it considers necessary or appropriate for deciding whether to acquire the Securities and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its subsidiaries and their respective financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. The Purchaser has sought such accounting, legal and tax advice as it has considered necessary to make an informed decision with respect to its acquisition of the Securities.

(f) Certain Trading Limitations. The Purchaser agrees that beginning on the date hereof until ninety (90) days from the Closing Date, it will not enter into any Short Sales. For purposes of this Section 3.2(f), a "Short Sale" means a sale of Common Stock that is marked as a short sale and that is executed at a time when Purchaser has no equivalent offsetting long position in the Common Stock. For purposes of determining whether the Purchaser has an equivalent offsetting long position in the Common Stock, all Common Stock and all Common Stock that would be issuable upon conversion or exercise in full of all options then held by Purchaser (assuming that such options were then fully convertible or exercisable, notwithstanding any provisions to the contrary, and giving effect to any conversion or exercise price adjustments scheduled to take effect in the future) shall be deemed to be held long by the Purchaser.

(g) Certain Fees. The Purchaser has not taken any action that would cause the Company to be liable for any brokerage or finder's fees or commissions payable to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person engaged by the Purchaser, if any, with respect to the transactions contemplated by this Agreement.

ARTICLE IV
OTHER AGREEMENTS OF THE PARTIES

4.1 Restricted Securities; Transfers on Restrictions. The Purchaser understands that (i) the Securities are characterized as "restricted securities" under the Securities Act; (ii) the Securities have not been and, except as otherwise provided herein, will not be registered under the Securities Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless subsequently registered thereunder or the Purchaser shall have delivered to the Company an opinion of counsel, in a generally acceptable form and from counsel reasonably acceptable to the Company, to the effect that such Securities to be sold, assigned or transferred may be sold, assigned or transferred pursuant to an exemption from such registration, (iii) any sale of the Securities made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144, and further, if Rule 144 is not applicable, any resale of the Securities under circumstances in which the seller (or the Person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the Securities Act) may require compliance with some other exemption under the Securities Act or the rules and regulations of the Commission promulgated thereunder; and (iv) unless sold pursuant to a registration statement that has been declared effective under the Securities Act or in compliance with Rule 144, the Company requires that the Securities bear a legend referring to the foregoing restrictions (it being agreed that if the Securities are not certificated, other appropriate restrictions shall be implemented to give effect to the foregoing) and shall place stop order instructions with its transfer agent with respect to such Securities.

4.2 Integration. The Company shall not, and shall use its best efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities to the Purchaser, or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market.

4.3 Reservation of Securities. The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the Transaction Documents in such amount as may be required to fulfill its obligations in full under the Transaction Documents. In the event that at any time the then authorized shares of Common Stock are insufficient for the Company to satisfy its obligations in full under the Transaction Documents, the Company shall promptly take such actions as may be required to increase the number of authorized shares.

4.4 Piggy-Back Registrations.

(a) Until such time as the Registrable Securities (as defined below) may be sold in accordance with Rule 144(b) under the Securities Act, if the Company at any time proposes to file on its behalf and/or on behalf of any of its security holders a registration statement under the Securities Act on any form (other than a registration statement on Form S4 or S-8 or any successor form or to the Company's employees pursuant to any employee benefit plan, respectively) for the general registration of securities to be sold for cash with respect to the Common Stock, it will give written notice to the Purchaser at least ten (10) days before the initial filing with the Commission of the registration statement (or, in the case of a registration statement that has already been filed with the Commission but has not yet been declared effective, within ten (10) days before the anticipated effective date of the registration statement), which notice shall offer the Purchaser the opportunity to include in such registration statement the number of Registrable Securities as the Purchaser may request (a "Piggyback Registration"), subject to the provisions of Section 4.4(b) hereof. Upon the request of the Purchaser made within ten (10) days after the receipt of notice from the Company regarding a Piggyback Registration (which such request shall specify the number of Registrable Securities for which registration is being requested), the Company shall use its commercially reasonable efforts to effect the registration under the Securities Act of all Registrable Securities that the Company has been so requested to register by the Purchaser; provided that nothing in this Section 4.4(a) shall preclude the Company from discontinuing the registration of its securities being effected at any time and for any reason before the effective date of the registration relating thereto; but, in that event, the Company shall notify the Purchaser of such discontinuation of the registration. The Company shall pay all registration expenses in connection with each Piggyback Registration.

(b) If the lead managing underwriter of a proposed public offering by the Company shall advise the Company in writing that, in their good faith opinion, the number of Registrable Securities to be included in such registration would materially and adversely affect the marketing or price of the securities to be sold in the public offering, the Company will allocate the securities to be included in such registration statement in accordance with the following priority: (i) first, the securities to be included in such registration statement by the Company or the holder or holders initiating the registration statement; and (ii) next, the Registrable Securities requested to be included in such registration by the Holder.

ARTICLE V
MISCELLANEOUS

5.1 Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement.

5.2 Entire Agreement. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedule. At or after the Closing, and without further consideration, the Company will execute and deliver to the Purchaser such further documents as may be reasonably requested in order to give practical effect to the intention of the parties under the Transaction Documents. Notwithstanding anything to the contrary herein, Securities may be assigned to any Person in connection with a bona fide margin account or other loan or financing arrangement secured by such Company Securities.

5.3 Notices. All notices and other communications required or permitted under this Agreement shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed telex or facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. The addresses and facsimile numbers for such notices and communications are those set forth on the signature pages hereof, or such other address or facsimile number as may be designated in writing hereafter upon five (5) days notice, in the same manner, by such Person.

5.4 Amendments: Waivers. No provision of this Agreement may be waived or amended except in a written instrument signed, in the case of an amendment, by the Company and the Purchaser or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought.

5.5 Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party.

5.6 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Purchaser. The Purchaser may assign its rights under this Agreement to any Person to whom Purchaser assigns or transfers any Securities, provided such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions hereof that apply to the "Purchaser." Notwithstanding anything to the contrary herein, Securities may be assigned to any Person in connection with a bona fide margin account or other loan or financing arrangement secured by such Securities.

5.7 No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

5.8 Governing Law: Venue: Waiver Of Jury Trail. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. THE COMPANY AND PURCHASER HEREBY IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN FOR THE ADJUDICATION OF ANY DISPUTE BROUGHT BY THE COMPANY OR PURCHASER HEREUNDER, IN CONNECTION HEREWITH OR WITH ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS), AND HEREBY IRREVOCABLY WAIVE, AND AGREE NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING BROUGHT BY THE COMPANY OR PURCHASER, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, OR THAT SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. THE COMPANY AND PURCHASER HEREBY WAIVE ALL RIGHTS TO A TRIAL BY JURY.

5.9 Survival. The representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery and/or exercise of the Securities, as applicable.

5.10 Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile or electronic transmission, including via PDF, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or electronic signature page were an original thereof.

5.11 Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Agreement.

5.12 Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Purchaser and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby agrees to waive in any action for specific performance of any such obligation the defense that a remedy at law would be adequate.

[SIGNATURE PAGES TO FOLLOW]

IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

		COMPANY: GRANDPARE.COM, INC. By: /s/ Steve Leber Name: Steve Leber Title: Chairman and Co-CEO Address for Notice: Grandparents.com, Inc. 589 Eighth Avenue, 6th floor New York New York 10018 Telephone: (646) 839-8809 Facsimile: (646) 654-6106 Attention: Matthew Schwartz, VP & Chief Compliance Officer With a copy to: Sills Cummis & Gross PC One Riverfront Plaza Newark, New Jersey 07102 Telephone: (973) 643-7000 Facsimile: (973) 643-6500 Attention: Jeffrey L. Wasserman, Esq. Purchaser: CV Starr & Company, Inc. By:/s/ Howard Smith Name: Howard Smith (for CV Starr & Company, Inc.) Address for Notice: Mr. Howard Smith 212-759-5855 Howard.smith@cvstarrcompanies.com

EXHIBIT A
Form of Warrant

See attached.

EX-99.7 3 exhibit-99-7.htm

Exhibit 99.7

THIS WARRANT AND THE UNDERLYING SHARES OF COMMON STOCK HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY OTHER SECURITIES LAWS, HAVE BEEN TAKEN FOR INVESTMENT, AND MAY NOT BE SOLD OR TRANSFERRED OR OFFERED FOR SALE OR TRANSFER UNLESS A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND OTHER APPLICABLE SECURITIES LAWS WITH RESPECT TO SUCH SECURITIES IS THEN IN EFFECT, OR IN THE OPINION OF COUNSEL TO THE ISSUER OF THESE SECURITIES, SUCH REGISTRATION UNDER THE SECURITIES ACT AND OTHER APPLICABLE SECURITIES LAWS IS NOT REQUIRED.

Date: June 16, 2014

Warrant # GP-155

WARRANT FOR THE PURCHASE OF SHARES OF
COMMON STOCK OF GRANDPARENTS.COM, INC.

THIS IS TO CERTIFY that, for value received, CV Starr & Company, Inc. and its successors and assigns (individually and collectively, the "Holder"), is entitled to purchase, subject to the terms and conditions hereinafter set forth, the Warrant Shares (as defined below) of common stock, $0.01 par value per share (the "Common Stock") of GRANDPARENTS.COM, INC., a Delaware corporation (the "Company"), and to receive certificates for the Common Stock so purchased. The exercise price of this Warrant is $0.25 per share (the "Exercise Price"). The term "Warrant Shares" shall mean One Million (1,000,000) shares of the Company (subject to adjustment as contemplated herein).

1. Exercise Period. This Warrant shall become exercisable by the Holder beginning upon the date set forth above and ending at 5:00 p.m., New York, New York time, five (5) years from the date of this Warrant (the "Exercise Period"). This Warrant will terminate automatically and immediately upon the expiration of the Exercise Period.

2. Exercise of Warrant; Cashless Exercise.

(a) Exercise. This Warrant may be exercised, in whole or in part, at any time and from time to time during the Exercise Period. Such exercise shall be accomplished by tender to the Company of an amount equal to the Exercise Price multiplied by the number of underlying shares being purchased (the "Purchase Price"), either (i) in cash, by wire transfer or by certified check or bank cashier's check, payable to the order of the Company, or (ii) by a "Cashless Exercise" as set forth in Section 2(b), together with presentation and surrender to the Company of this Warrant with an executed subscription agreement in substantially the form attached hereto as Exhibit A (the "Subscription"). Upon receipt of the foregoing, the Company will deliver to the Holder, as promptly as possible, a certificate or certificates representing the shares of Common Stock so purchased, registered in the name of the Holder or the Holder's transferee (as permitted under Section 3 below). With respect to any exercise of this Warrant, the Holder will for all purposes be deemed to have become the holder of record of the number of shares of Common Stock purchased hereunder on the date the Subscription has been properly executed and payment of the Purchase Price have both been received by the Company (the "Exercise Date"), irrespective of the date of delivery of the certificate evidencing such shares of the Common Stock, except that, if the date of such receipt is a date on which the stock transfer books of the Company are closed, such person will be deemed to have become the holder of such shares at the close of business on the next succeeding date on which the stock transfer books are open. Fractional shares of Common Stock will not be issued upon the exercise of this Warrant. In lieu of any fractional shares that would have been issued but for the immediately preceding sentence, the Holder will be entitled to receive cash equal to the current market price of such fraction of a share of Common Stock on the trading day immediately preceding the Exercise Date. In the event this Warrant is exercised in part, the Company shall issue a new Warrant to purchase Common Stock, in substantially the form of this Warrant (any such new Warrant, a "New Warrant") to the Holder covering the aggregate number of shares of Common Stock as to which this Warrant remains exercisable.

(b) Cashless Exercise. If the Holder elects to conduct a Cashless Exercise, the Company shall cause to be delivered to the Holder a certificate or certificates representing the number of shares of Common Stock computed using the following formula:

X = Y (A-B)

Where:

X = the number of shares of Common Stock to be issued to Holder;

Y = the portion of this Warrant (in number of shares of Common

Stock) being exercised by Holder (at the date of such calculation);

A = the Fair Market Value (as defined below) of one share of Common

Stock on the Exercise Date, calculated by taking the average Fair Market Value over the last ten (10) trading days (not including the Exercise Date); and

B = Warrant Price (as adjusted to the date of such calculation).

(c) Definition of Fair Market Value. For purposes of this Warrant, "Fair Market Value" shall mean: (i) if the principal trading market for such securities is a national securities exchange or the Over-the-Counter Bulletin Board (or a similar system then in use), the average of the last reported sales price on the principal market for each of the ten (10) trading days immediately prior to such Exercise Date; or (ii) if clause (i) is not applicable, and if bid and ask prices for shares of Common Stock are reported by the principal trading market or the Pink Sheets, the average of the average of the high bid and low ask prices so reported for each of the ten (10) trading days immediately prior to such Exercise Date. Notwithstanding the foregoing, if there is no last reported sales price or bid and ask prices, as the case may be, for the day in question, then Fair Market Value shall be determined as of the latest day prior to such day for which such last reported sales price or bid and ask prices, as the case may be, are available, unless such securities have not been traded on an exchange or in the over-the-counter market for thirty (30) or more days immediately prior to the day in question, in which case the Fair Market Price shall be determined in good faith by, and reflected in a formal resolution of, the board of directors of the Company.

3. Recording, Transferability, Exchange and Obligations to Issue Common Stock.

(a) Registration of Warrant. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the "Warrant Register"), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary from the transferee and transferor.

(b) Registration of Transfers. The Company shall register the transfer of any portion of this Warrant in the Warrant Register, upon surrender of this Warrant, with the Form of Assignment attached hereto as Exhibit B duly completed and signed, to the Company at its address specified herein. As a condition to the transfer, the Company may request a legal opinion as contemplated by the legend. Upon any such registration or transfer, a New Warrant evidencing the portion of this Warrant so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and obligations of a holder of a Warrant.

(c) Exchange of Warrant. This Warrant is exchangeable upon its surrender by the Holder to the Company for one or more New Warrants of like tenor and date representing the right to purchase the number of shares purchasable hereunder, each of such New Warrant to represent the right to purchase such number of shares as may be designated by the Holder at the time of such surrender (not to exceed the aggregate number of shares underlying this Warrant).

(d) Obligation to Deliver Common Stock. The Company's obligations to issue and deliver Common Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with the issuance of Common Stock. Nothing herein shall limit the Holder's right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company's failure to timely deliver certificates representing shares of Common Stock upon exercise of this Warrant as required pursuant to the terms hereof.

4. Adjustments to Exercise Price and Number of Shares Subject to Warrant. The Exercise Price and the number of shares of Common Stock purchasable upon the exercise of this Warrant are subject to adjustment from time to time upon the occurrence of any of the events specified in this Section 4. For the purpose of this Section 4, "Common Stock" means shares now or hereafter authorized of any class of common stock of the Company, however designated, that has the right to participate in any distribution of the assets or earnings of the Company without limit as to per share amount (excluding, and subject to any prior rights of, any class or series of preferred stock).

(a) In case the Company shall (i) pay a dividend or make a distribution in shares of Common Stock to holders of shares of Common Stock, (ii) subdivide its outstanding shares of Common Stock into a greater number of shares, (iii) combine its outstanding shares of Common Stock into a smaller number of shares, or (iv) issue by reclassification of its shares of Common Stock other securities of the Company, then the Exercise Price in effect at the time of the record date for such dividend or on the effective date of such subdivision, combination or reclassification, and/or the number and kind of securities issuable on such date, shall be proportionately adjusted so that the Holder of this Warrant thereafter exercised shall be entitled to receive the aggregate number and kind of shares of Common Stock (or such other securities other than Common Stock) of the Company, at the same aggregate Exercise Price, that, if such Warrant had been exercised immediately prior to such date, the Holder would have been issued upon such exercise and been entitled to receive by virtue of such dividend, distribution, subdivision, combination or reclassification. Such adjustment shall be made successively whenever any event listed above shall occur.

(b) In case the Company shall fix a record date for the making of a distribution to all holders of Common Stock (including any such distribution made in connection with a consolidation or merger in which the Company is the surviving corporation) of cash, evidences of indebtedness or assets, or subscription rights or warrants, the Exercise Price to be in effect after such record date shall be determined by multiplying the Exercise Price in effect immediately prior to such record date by a fraction, the numerator of which shall be the Fair Market Value per share of Common Stock on such record date, less the amount of cash so to be distributed or the Fair Market Value (as determined in good faith by, and reflected in a formal resolution of, the board of directors of the Company) of the portion of the assets or evidences of indebtedness so to be distributed, or of such subscription rights or warrants, applicable to one share of Common Stock, and the denominator of which shall be the Fair Market Value per share of Common Stock. Such adjustment shall be made successively whenever such a record date is fixed; and in the event that such distribution is not so made, the Exercise Price shall again be adjusted to be the Exercise Price which would then be in effect if such record date had not been fixed.

(c) Notwithstanding any provision herein to the contrary, no adjustment in the Exercise Price shall be required unless such adjustment would require an increase or decrease of at least 1% in the Exercise Price; provided, however, that any adjustments which by reason of this Section 4(c) are not required to be made shall be carried forward and taken into account in any subsequent adjustment. All calculations under this Section 4 shall be made to the nearest cent or the nearest one-hundredth of a share, as the case may be.

(d) In the event that at any time, as a result of an adjustment made pursuant to Section 4(a) above, the Holder shall become entitled to receive any shares of capital stock of the Company other than shares of Common Stock, thereafter the number of such other shares so receivable upon exercise of this Warrant shall be subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the shares of Common Stock contained in this Section 4, and the other provisions of this Warrant shall apply on like terms to any such other shares.

(e) If, at any time while this Warrant is outstanding, (i) the Company effects any merger or consolidation of the Company with or into another company, (ii) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (iii) any tender offer or exchange offer (whether by the Company or another company or person) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares for other securities, cash or property, or (iv) the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (in any such case, a "Fundamental Transaction"), then the Holder shall have the right thereafter to receive, upon exercise in full of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Common Stock then issuable upon exercise in full of this Warrant (the "Alternate Consideration"). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. At the Holder's option and request, any successor to the Company or surviving entity in such Fundamental Transaction shall issue to the Holder a New Warrant substantially in the form of this Warrant and consistent with the foregoing provisions and evidencing the Holder's right to purchase the Alternate Consideration for the aggregate Exercise Price upon exercise thereof. Any such successor or surviving entity shall be deemed to be required to comply with the provisions of this Section 4(e) and shall insure that this Warrant (or any such replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction.

(f) In case any event shall occur as to which the other provisions of this Section 4 are not strictly applicable but the failure to make any adjustment would not fairly protect the purchase rights represented by this Warrant in accordance with the essential intent and principles hereof, then, in each such case, the Company shall effect such adjustment, on a basis consistent with the essential intent and principles established in this Section 4, as may be necessary to preserve, without dilution, the purchase rights represented by this Warrant.

(g) Upon the occurrence of each adjustment pursuant to this Section 4, the Company at its expense will promptly compute such adjustment in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a statement of the adjusted Exercise Price and adjusted number or type of Common Stock or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder and to the Company's Transfer Agent.

5. Registration Rights.

(a) This Warrant has not been registered under the Securities Act of 1933, as amended (the "Securities Act"). When exercised, the stock certificates shall bear the following legend unless the Warrant Shares may be publicly sold under Rule 144(b)(1) of the Securities Act (or successor rule) or registered under the Securities Act pursuant to an effective registration statement filed with the Securities and Exchange Commission (the "Commission").

"The securities represented by this certificate have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), and may not be offered for sale or sold except pursuant to (i) an effective registration statement under the Securities Act, or (ii) an opinion of counsel, if such opinion and counsel shall be reasonably satisfactory to counsel to the issuer, that an exemption from registration under the Securities Act is available."

(b) Until such time as the Registrable Securities (as defined below) may be sold in accordance with Rule 144(b) under the Securities Act, if the Company at any time proposes to file on its behalf and/or on behalf of any of its security holders a registration statement under the Securities Act on any form (other than a registration statement on Form S-4 or S-8 or any successor form or to the Company's employees pursuant to any employee benefit plan, respectively) for the general registration of securities to be sold for cash with respect to the Common Stock, it will give written notice to the Holder at least ten (10) days before the initial filing with the Commission of the registration statement (or, in the case of a registration statement that has already been filed with the Commission but has not yet been declared effective, within ten (10) days before the anticipated effective date of the registration statement), which notice shall offer the Holder the opportunity to include in such registration statement the number of Registrable Securities as the Holder may request (a "Piggyback Registration"), subject to the provisions of Section 5(c) hereof. Upon the request of the Holder made within ten (10) days after the receipt of notice from the Company regarding a Piggyback Registration (which such request shall specify the number of Registrable Securities for which registration is being requested), the Company shall use its commercially reasonable efforts to effect the registration under the Securities Act of all Registrable Securities that the Company has been so requested to register by the Holder; provided that nothing in this Section 5(b) shall preclude the Company from discontinuing the registration of its securities being effected at any time and for any reason before the effective date of the registration relating thereto; but, in that event, the Company shall notify the Holder of such discontinuation of the registration. The Company shall pay all registration expenses in connection with each Piggyback Registration.

(c) If the lead managing underwriter of a proposed public offering by the Company shall advise the Company in writing that, in their good faith opinion, the number of Registrable Securities to be included in such registration would materially and adversely affect the marketing or price of the securities to be sold in the public offering, the Company will allocate the securities to be included in such registration statement in accordance with the following priority: (i) first, the securities to be included in such registration statement by the Company or the holder or holders initiating the registration statement; and (ii) next, the Registrable Securities requested to be included in such registration by the Holder.

(d) All fees and expenses incidental to the performance of or compliance with the filing of a registration statement in connection with a Piggyback Registration (the "Registration Statement") will be borne by the Company, including, without limitation, registration, filing, and qualification fees; printers' and accounting fees; fees and disbursements of counsel for the Company. In no event will the Company be responsible for any broker or similar commissions or, except to the extent provided for hereunder, any legal fees or other costs of the Holder.

(e) The Company will indemnify and hold harmless the Holder, its officers, directors, agents and employees, and each person who controls the Holder (within the meaning of Section 15 of the Securities Act) and the officers, directors, agents and employees of each such controlling person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys' fees) and expenses (collectively, "Losses"), as incurred, arising out of or relating to any untrue or alleged untrue statement of a material fact contained in the Registration Statement, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, except to the extent, but only to the extent: (i) that such untrue statements or omissions are based solely upon information regarding the Holder furnished in writing to the Company by the Holder expressly for use in the Registration Statement; or (ii) of the Holder's use of an outdated or defective Registration Statement after the Company has notified the Holder in writing that the Registration Statement is outdated or defective.

(f) The Holder will indemnify and hold harmless the Company, its directors, officers, agents and employees, each person who controls the Company (within the meaning of Section 15 of the Securities Act), and the directors, officers, agents or employees of such controlling persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: (i) the Holder's failure to comply with the prospectus delivery requirements of the Securities Act; or (ii) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading to the extent that such untrue statements or omissions are based solely upon information regarding the Holder furnished in writing to the Company by the Holder expressly for use in the Registration Statement; or (iii) the use by the Holder of an outdated or defective Registration Statement after the Company has notified the Holder in writing that the Registration Statement is outdated or defective. In no event will the liability of the Holder hereunder be greater in amount than the dollar amount of the net proceeds received by the Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

(g) "Registrable Securities" means (i) any of the Warrant Shares issued or issuable upon the exercise of this Warrant and (ii) any shares of Common Stock issued or to be issued with respect to the Common Stock issued or issuable upon the exercise of this Warrant by way of a stock dividend or stock split. As to any particular Registrable Security, such security will cease to be a Registrable Security when it (x) has been effectively registered under the Securities Act and disposed of in accordance with the registration statement covering such security, (y) has been transferred through a broker-dealer in an open market transaction pursuant to Rule 144 (or any similar provision then in force) or (z) is eligible for sale pursuant to Rule 144(b) (or any similar provision then in force).

6. Reservation of Common Stock. The Company covenants that it will at all times reserve and keep available out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue Common Stock upon exercise of this Warrant as herein provided, the number of shares of Common Stock which are then issuable and deliverable upon the exercise in full of this Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the Holder (taking into account the adjustments and restrictions of Section 4). The Company covenants that all Common Stock so issuable and deliverable shall, upon issuance and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized, issued and fully paid and nonassessable.

7. Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity (which may include a surety bond), if requested. Applicants for a New Warrant under such circumstances shall also comply with such other reasonable regulations and procedures and pay such other reasonable third-party costs as the Company may prescribe. If a New Warrant is requested as a result of a mutilation of this Warrant, then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company's obligation to issue the New Warrant.

8. Charges, Taxes and Expenses. Issuance and delivery of certificates for shares of Common Stock upon exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax, withholding tax, transfer agent fee or other incidental tax or expense in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the registration of any certificates for Common Stock or warrant in a name other than that of the Holder. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Common Stock upon exercise hereof.

9. Notices to Holder. In the event of (a) any fixing by the Company of a record date with respect to the holders of any class of securities of the Company for the purpose of determining which of such holders are entitled to dividends or other distributions, or any rights to subscribe for, purchase or otherwise acquire any shares of capital stock of any class or any other securities or property, or to receive any other right, (b) any capital reorganization of the Company, or reclassification or recapitalization of the capital stock of the Company or any transfer of all or substantially all of the assets or business of the Company to, or consolidation or merger of the Company with or into, any other entity or person, or (c) any voluntary or involuntary dissolution or winding up of the Company, then and in each such event the Company will give the Holder a written notice specifying, as the case may be (i) the record date for the purpose of such dividend, distribution, or right, and stating the amount and character of such dividend, distribution, or right; or (ii) the date on which any such reorganization, reclassification, recapitalization, transfer, consolidation, merger, conveyance, dissolution, liquidation, or winding up is to take place and the time, if any is to be fixed, as of which the holders of record of Common Stock (or such capital stock or securities receivable upon the exercise of this Warrant) shall be entitled to exchange their shares of Common Stock (or such other stock securities) for securities or other property deliverable upon such event. Any such notice shall be given at least ten (10) days prior to the earliest date therein specified.

10. No Rights as a Stockholder. This Warrant does not entitle the Holder to any voting rights or other rights as a stockholder of the Company, nor to any other rights whatsoever except the rights herein set forth; provided, however, that the Company shall not close any merger agreement in which it is not the surviving entity, or sell all or substantially all of its assets unless the Company shall have first provided the Holder with at least ten (10) days' prior written notice.

11. Additional Covenants of the Company.

(a) If upon issuance of any shares for which this Warrant is exercisable the Common Stock is listed for trading or trades on any national securities exchange, then upon the issuance, the Company shall, at its expense, promptly obtain and maintain the listing or qualifications for trading of such shares.

(b) The Company shall comply with the reporting requirements of Section 13 of the Exchange Act for so long as and to the extent that such requirements apply to the Company.

(c) The Company shall not, by amendment of its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issuance or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant. Without limiting the generality of the foregoing, the Company (i) will at all times reserve and keep available, solely for issuance and delivery upon exercise of this Warrant, shares of Common Stock issuable from time to time upon exercise of this Warrant, (ii) will not increase the par value of any shares of Common Stock issuable upon exercise of this Warrant above the amount payable therefor upon such exercise, and (c) will take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable stock.

12. Successors and Assigns. This Warrant shall be binding upon and inure to the benefit of the Company, the Holder and their respective successors and permitted assigns.

13. Severability. Every provision of this Warrant is intended to be severable. If any term or provision hereof is illegal or invalid for any reason whatsoever, such illegality or invalidity shall not affect the remainder of this Warrant.

14. Governing Law. This Warrant shall be governed by and construed in accordance with the laws of the State of Delaware as of the time of construction without giving effect to the principles of choice of laws thereof.

15. Attorneys' Fees. In any action or proceeding brought to enforce any provision of this Warrant, the prevailing party shall be entitled to recover reasonable attorneys' fees in addition to its costs and expenses and any other available remedies.

16. Good Faith. The Company will at all times act in good faith assist in the carrying out of all terms and obligations set forth in this Warrant, and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder.

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its duly authorized officer as of the date first set forth above.

	GRANDPARENTS.COM, INC.

	By: /s/ Steve Leber
	Name: Steve Leber
	Title: Chairman & CEO